메뉴 건너뛰기




Volumn 25, Issue 10, 2006, Pages 1699-1714

Decision-theoretic designs for dose-finding clinical trials with multiple outcomes

Author keywords

Bandit process; Optimality; Sequential clinical trials; Sub optimality

Indexed keywords

ANTIRETROVIRUS AGENT; IFOSFAMIDE;

EID: 33646809350     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2322     Document Type: Article
Times cited : (4)

References (22)
  • 1
    • 0028279806 scopus 로고
    • Practical Bayesian guidelines for phase IIb clinical trials
    • Thall PF, Simon R. Practical Bayesian guidelines for phase IIb clinical trials. Biometrics 1994; 50:337-349.
    • (1994) Biometrics , vol.50 , pp. 337-349
    • Thall, P.F.1    Simon, R.2
  • 2
    • 0032885857 scopus 로고    scopus 로고
    • Decision theoretic designs for phase II clinical trials with multiple outcomes
    • Stallard N, Thall P, Whitehead J. Decision theoretic designs for phase II clinical trials with multiple outcomes. Biometrics 1999; 55:971-977.
    • (1999) Biometrics , vol.55 , pp. 971-977
    • Stallard, N.1    Thall, P.2    Whitehead, J.3
  • 3
    • 27144518391 scopus 로고    scopus 로고
    • An optimal sequential design for screening trials
    • Wang Y-G, Leung DH. An optimal sequential design for screening trials. Biometrics 1998; 54:245-252.
    • (1998) Biometrics , vol.54 , pp. 245-252
    • Wang, Y.-G.1    Leung, D.H.2
  • 4
    • 0035186577 scopus 로고    scopus 로고
    • Decision-theoretic designs for pre-phase II screening trials in oncology
    • Stallard N, Thall PF. Decision-theoretic designs for pre-phase II screening trials in oncology. Biometrics 2001; 57:1089-1095.
    • (2001) Biometrics , vol.57 , pp. 1089-1095
    • Stallard, N.1    Thall, P.F.2
  • 5
    • 0038545822 scopus 로고    scopus 로고
    • Decision-theoretic designs for phase II clinical trials allowing for competing studies
    • Stallard N. Decision-theoretic designs for phase II clinical trials allowing for competing studies. Biometrics 2003; 59:402-409.
    • (2003) Biometrics , vol.59 , pp. 402-409
    • Stallard, N.1
  • 6
    • 0029071328 scopus 로고
    • Bayesian decision procedures for dose determining experiments (disc: P897-899)
    • Whitehead J, Brunier H. Bayesian decision procedures for dose determining experiments (disc: P897-899). Statistics in Medicine 1995; 14:885-893.
    • (1995) Statistics in Medicine , vol.14 , pp. 885-893
    • Whitehead, J.1    Brunier, H.2
  • 7
    • 0037080851 scopus 로고    scopus 로고
    • An extension of the continual reassessment method using decision theory
    • Leung D, Wang Y-G. An extension of the continual reassessment method using decision theory. Statistics in Medicine 2002; 21:51-63.
    • (2002) Statistics in Medicine , vol.21 , pp. 51-63
    • Leung, D.1    Wang, Y.-G.2
  • 10
    • 0001919041 scopus 로고
    • Sequential allocation involving several treatments
    • Institute of Mathematical Statistics: Hayward, CA
    • Coad DS. Sequential allocation involving several treatments. Adaptive Designs. Institute of Mathematical Statistics: Hayward, CA, 1995; 95-105.
    • (1995) Adaptive Designs , pp. 95-105
    • Coad, D.S.1
  • 11
    • 0035106433 scopus 로고    scopus 로고
    • A Bayesian decision approach for sample size determination in Phase II trials
    • Leung DH, Wang YG. A Bayesian decision approach for sample size determination in Phase II trials. Biometrics 2001; 57:309-312.
    • (2001) Biometrics , vol.57 , pp. 309-312
    • Leung, D.H.1    Wang, Y.G.2
  • 13
    • 0025148278 scopus 로고
    • Continual reassessment method: A practical design for Phase 1 clinical trials in cancer
    • O'Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for Phase 1 clinical trials in cancer. Biometrics 1990; 46:33-48.
    • (1990) Biometrics , vol.46 , pp. 33-48
    • O'Quigley, J.1    Pepe, M.2    Fisher, L.3
  • 14
    • 0036277621 scopus 로고    scopus 로고
    • The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes
    • Braun T. The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomes. Controlled Clinical Trial 2002; 23:240-256.
    • (2002) Controlled Clinical Trial , vol.23 , pp. 240-256
    • Braun, T.1
  • 15
    • 2142670647 scopus 로고    scopus 로고
    • Dose-finding based on multiple toxicities in a soft tissue sarcoma trial
    • Bekele B, Thall P. Dose-finding based on multiple toxicities in a soft tissue sarcoma trial. Journal of the American Statistical Association 2004; 99:26-35.
    • (2004) Journal of the American Statistical Association , vol.99 , pp. 26-35
    • Bekele, B.1    Thall, P.2
  • 16
    • 0035186085 scopus 로고    scopus 로고
    • Dose-finding designs for HIV studies
    • O'Quigley J, Hughes DM, Fenton T. Dose-finding designs for HIV studies. Biometrics 2001; 57:1018-1029.
    • (2001) Biometrics , vol.57 , pp. 1018-1029
    • O'Quigley, J.1    Hughes, D.M.2    Fenton, T.3
  • 17
    • 0018767566 scopus 로고
    • Stoppable families of alternative bandit processes
    • Glazebrook KD. Stoppable families of alternative bandit processes. Journal of Applied Probability 1979; 16: 843-854.
    • (1979) Journal of Applied Probability , vol.16 , pp. 843-854
    • Glazebrook, K.D.1
  • 19
    • 0032887598 scopus 로고    scopus 로고
    • Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials
    • Thall PF, Cheng S. Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials. Biometrics 1999; 55:746-753.
    • (1999) Biometrics , vol.55 , pp. 746-753
    • Thall, P.F.1    Cheng, S.2
  • 20
    • 0031953966 scopus 로고    scopus 로고
    • A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trial
    • Thall PF, Russell K. A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trial. Biometrics 1998; 54:251-264.
    • (1998) Biometrics , vol.54 , pp. 251-264
    • Thall, P.F.1    Russell, K.2
  • 21
    • 33746402001 scopus 로고    scopus 로고
    • Consistency of continual reassessment method under model misspecification
    • Shen LZ, O'Quigley J. Consistency of continual reassessment method under model misspecification. Biometrika 1996; 83:395-405.
    • (1996) Biometrika , vol.83 , pp. 395-405
    • Shen, L.Z.1    O'Quigley, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.